INS and neoplasm: Similarly, increased insulin signaling due to elevated circulating insulin levels contributes to enhanced tumor growth [30], which along with hyperglycemic effects on tumor cells, suggests enhanced metabolism as a contributing factor to ovarian cancer progression.